NYSEArca - Nasdaq Real Time Price USD

Defiance Next Gen Altered Experience ETF (PSY)

5.90 -0.03 (-0.51%)
As of August 29 at 4:00 PM EDT. Market Open.
Loading Chart for PSY
DELL
  • Previous Close 5.93
  • Open 5.92
  • Bid --
  • Ask --
  • Day's Range 5.84 - 5.91
  • 52 Week Range 5.84 - 5.91
  • Volume 20,616
  • Avg. Volume 0
  • Net Assets 4.68M
  • NAV 5.93
  • PE Ratio (TTM) --
  • Yield 6.05%
  • YTD Daily Total Return -50.08%
  • Beta (5Y Monthly) 0.00
  • Expense Ratio (net) 0.75%

The index is a rules-based index that tracks the performance of a portfolio of companies conducting legal activities under the national laws of the applicable country related to medical psychedelics, medical cannabis, cannabis pharmaceuticals and cannabidiol derivatives, and ketamine. The fund uses a “replication” strategy to achieve its investment objective, it will invest in all of the component securities of the index in the same approximate proportions as in the index. It is non-diversified.

Defiance ETFs

Fund Family

Miscellaneous Sector

Fund Category

4.68M

Net Assets

2021-05-27

Inception Date

Performance Overview: PSY

Trailing returns as of 9/1/2022. Category is Miscellaneous Sector.

YTD Return

PSY
50.08%
Category
--
 

1-Year Return

PSY
71.25%
Category
--
 

3-Year Return

PSY
0.00%
Category
--
 

Holdings: PSY

Top 10 Holdings (66.92% of Total Assets)

SymbolCompany% Assets
CRON.TO
Cronos Group Inc. 9.98%
CMPS
COMPASS Pathways plc 8.88%
ATAI
Atai Life Sciences N.V. 7.48%
MMED
MMED 6.56%
GRWG
GrowGeneration Corp. 6.41%
SEEL
Seelos Therapeutics, Inc. 6.17%
XXII
22nd Century Group, Inc. 5.64%
CRDL.TO
Cardiol Therapeutics Inc. 5.41%
IIPR
Innovative Industrial Properties, Inc. 5.24%
CWEB.TO
Charlotte's Web Holdings, Inc. 5.15%

Sector Weightings

SectorPSY
Healthcare   82.68%
Real Estate   5.25%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Related ETF News

Research Reports: PSY

  • NSA: Lowering target price to $67.00

    NATIONAL STORAGE AFFILIATES has an Investment Rating of BUY; a target price of $67.000000; an Industry Subrating of Medium; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of High; a Growth Subrating of High; and a Value Subrating of High.

    Rating
    Price Target
     
  • Analyst Report: Johnson & Johnson

    Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. Geographically, just over half of total sales are generated in the United States.

    Rating
    Price Target
     
  • ILPT: What does Argus have to say about ILPT?

    INDUSTRIAL LOGISTICS PROPERT has an Investment Rating of BUY; a target price of $33.000000; an Industry Subrating of Medium; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of High; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
     
  • ILPT: Raising target price to $33.00

    INDUSTRIAL LOGISTICS PROPERT has an Investment Rating of BUY; a target price of $33.000000; an Industry Subrating of Medium; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of High; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
     

Related Tickers